Under-utilization of echocardiography in the management of congestive heart failure in the community has adverse effects on morbidity and mortality

Michele Senni, Richard R. Rodeheffer, Jonathan M. Evans, Steven J. Jacobson, Kent R Bailey, Margaret May Redfield

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Knowledge of cardiac structure and function is believed important in the management of patients (pts) with congestive heart failure (CHF) and ACC/AHA clinical practice guidelines recommend echocardiography (echo) in all pts with suspected CHF. The utilization of echo in the management of CHF in the community is unknown. Using the Rochester epidemiology project, we evaluated the use of echo in all pts receiving a new diagnosis(dx) of CHF in Olmsted County, MN in 1991. Only pts who satisfied Framingham Criteria for CHF were included (n= 232). In all, 84 (36%) pts did not undergo echo (or other assessment of EF) within 3 weeks before or after the dx of CHF. Characteristics of the No Echo and Echo groups are outlined below. ACEi=Angiotensin Converting Enzyme Inhibitor, Subseq.Hosp.= Subsequent hospitalization for CHF CHF-No Echo CHF-Echo p value Age (yrs,±sd) 81±10 75±14 0.002 Female (%) 68 55 0.07 NYHA II (%) 71 27 <0.001 CAD (%) 33 30 NS ACEi use(%) 26 55 <0.001 Digoxin use(%) 32 45 0.072 Subseq.Hosp. 52 72 <0.001 Both groups showed reduced survival as compared to age and sex matched populations. By multivariate analysis controlling for age, NYHA functional class and sex, having an echo was associated with a lower risk of death (RR=0.661, p=0.03). The No Echo pts were older and more likely to be female. While the No-Echo pts had milder symptoms at dx, 52% were later hospitalized for CHF-possibly related to under-treatment with digoxin and ACEi. In conclusion, underutilization of Echo in the management of CHF in the community appears to have an adverse effect on morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)428
Number of pages1
JournalJournal of the American Society of Echocardiography
Volume10
Issue number4
StatePublished - 1997

Fingerprint

Echocardiography
Heart Failure
Morbidity
Mortality
Digoxin
Practice Guidelines
Angiotensin-Converting Enzyme Inhibitors
Epidemiology
Hospitalization
Multivariate Analysis
Survival

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Under-utilization of echocardiography in the management of congestive heart failure in the community has adverse effects on morbidity and mortality. / Senni, Michele; Rodeheffer, Richard R.; Evans, Jonathan M.; Jacobson, Steven J.; Bailey, Kent R; Redfield, Margaret May.

In: Journal of the American Society of Echocardiography, Vol. 10, No. 4, 1997, p. 428.

Research output: Contribution to journalArticle

@article{2ab5a4f692d94eea8ce7e2dd09b81d24,
title = "Under-utilization of echocardiography in the management of congestive heart failure in the community has adverse effects on morbidity and mortality",
abstract = "Knowledge of cardiac structure and function is believed important in the management of patients (pts) with congestive heart failure (CHF) and ACC/AHA clinical practice guidelines recommend echocardiography (echo) in all pts with suspected CHF. The utilization of echo in the management of CHF in the community is unknown. Using the Rochester epidemiology project, we evaluated the use of echo in all pts receiving a new diagnosis(dx) of CHF in Olmsted County, MN in 1991. Only pts who satisfied Framingham Criteria for CHF were included (n= 232). In all, 84 (36{\%}) pts did not undergo echo (or other assessment of EF) within 3 weeks before or after the dx of CHF. Characteristics of the No Echo and Echo groups are outlined below. ACEi=Angiotensin Converting Enzyme Inhibitor, Subseq.Hosp.= Subsequent hospitalization for CHF CHF-No Echo CHF-Echo p value Age (yrs,±sd) 81±10 75±14 0.002 Female ({\%}) 68 55 0.07 NYHA II ({\%}) 71 27 <0.001 CAD ({\%}) 33 30 NS ACEi use({\%}) 26 55 <0.001 Digoxin use({\%}) 32 45 0.072 Subseq.Hosp. 52 72 <0.001 Both groups showed reduced survival as compared to age and sex matched populations. By multivariate analysis controlling for age, NYHA functional class and sex, having an echo was associated with a lower risk of death (RR=0.661, p=0.03). The No Echo pts were older and more likely to be female. While the No-Echo pts had milder symptoms at dx, 52{\%} were later hospitalized for CHF-possibly related to under-treatment with digoxin and ACEi. In conclusion, underutilization of Echo in the management of CHF in the community appears to have an adverse effect on morbidity and mortality.",
author = "Michele Senni and Rodeheffer, {Richard R.} and Evans, {Jonathan M.} and Jacobson, {Steven J.} and Bailey, {Kent R} and Redfield, {Margaret May}",
year = "1997",
language = "English (US)",
volume = "10",
pages = "428",
journal = "Journal of the American Society of Echocardiography",
issn = "0894-7317",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Under-utilization of echocardiography in the management of congestive heart failure in the community has adverse effects on morbidity and mortality

AU - Senni, Michele

AU - Rodeheffer, Richard R.

AU - Evans, Jonathan M.

AU - Jacobson, Steven J.

AU - Bailey, Kent R

AU - Redfield, Margaret May

PY - 1997

Y1 - 1997

N2 - Knowledge of cardiac structure and function is believed important in the management of patients (pts) with congestive heart failure (CHF) and ACC/AHA clinical practice guidelines recommend echocardiography (echo) in all pts with suspected CHF. The utilization of echo in the management of CHF in the community is unknown. Using the Rochester epidemiology project, we evaluated the use of echo in all pts receiving a new diagnosis(dx) of CHF in Olmsted County, MN in 1991. Only pts who satisfied Framingham Criteria for CHF were included (n= 232). In all, 84 (36%) pts did not undergo echo (or other assessment of EF) within 3 weeks before or after the dx of CHF. Characteristics of the No Echo and Echo groups are outlined below. ACEi=Angiotensin Converting Enzyme Inhibitor, Subseq.Hosp.= Subsequent hospitalization for CHF CHF-No Echo CHF-Echo p value Age (yrs,±sd) 81±10 75±14 0.002 Female (%) 68 55 0.07 NYHA II (%) 71 27 <0.001 CAD (%) 33 30 NS ACEi use(%) 26 55 <0.001 Digoxin use(%) 32 45 0.072 Subseq.Hosp. 52 72 <0.001 Both groups showed reduced survival as compared to age and sex matched populations. By multivariate analysis controlling for age, NYHA functional class and sex, having an echo was associated with a lower risk of death (RR=0.661, p=0.03). The No Echo pts were older and more likely to be female. While the No-Echo pts had milder symptoms at dx, 52% were later hospitalized for CHF-possibly related to under-treatment with digoxin and ACEi. In conclusion, underutilization of Echo in the management of CHF in the community appears to have an adverse effect on morbidity and mortality.

AB - Knowledge of cardiac structure and function is believed important in the management of patients (pts) with congestive heart failure (CHF) and ACC/AHA clinical practice guidelines recommend echocardiography (echo) in all pts with suspected CHF. The utilization of echo in the management of CHF in the community is unknown. Using the Rochester epidemiology project, we evaluated the use of echo in all pts receiving a new diagnosis(dx) of CHF in Olmsted County, MN in 1991. Only pts who satisfied Framingham Criteria for CHF were included (n= 232). In all, 84 (36%) pts did not undergo echo (or other assessment of EF) within 3 weeks before or after the dx of CHF. Characteristics of the No Echo and Echo groups are outlined below. ACEi=Angiotensin Converting Enzyme Inhibitor, Subseq.Hosp.= Subsequent hospitalization for CHF CHF-No Echo CHF-Echo p value Age (yrs,±sd) 81±10 75±14 0.002 Female (%) 68 55 0.07 NYHA II (%) 71 27 <0.001 CAD (%) 33 30 NS ACEi use(%) 26 55 <0.001 Digoxin use(%) 32 45 0.072 Subseq.Hosp. 52 72 <0.001 Both groups showed reduced survival as compared to age and sex matched populations. By multivariate analysis controlling for age, NYHA functional class and sex, having an echo was associated with a lower risk of death (RR=0.661, p=0.03). The No Echo pts were older and more likely to be female. While the No-Echo pts had milder symptoms at dx, 52% were later hospitalized for CHF-possibly related to under-treatment with digoxin and ACEi. In conclusion, underutilization of Echo in the management of CHF in the community appears to have an adverse effect on morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=12944329705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944329705&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 428

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

SN - 0894-7317

IS - 4

ER -